Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Reinforcement
下丘脑分泌素/食欲素对多巴胺信号传导和可卡因强化的调节
基本信息
- 批准号:10408008
- 负责人:
- 金额:$ 37.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAnimalsArousalAttenuatedBehavioralBiochemistryBrainChronic DiseaseCocaineCocaine DependenceCuesDevelopmentDopamineDopamine AgonistsDrug DesignDrug abuseDrug usageHumanHypothalamic structureInjectionsInstitutesLeadMediatingMedicalMotivationMotor ActivityNeuropeptidesNucleus AccumbensPeptidesPeriodicityPharmaceutical PreparationsPharmacologyPharmacotherapyPhasePost-Translational Protein ProcessingProcessPsychological reinforcementPublic HealthRattusRecoveryRegulationReinforcement ScheduleRelapseReportingResearchResistanceRewardsScanningSignal TransductionSystemTechniquesTestingVentral Tegmental AreaWorkabuse liabilityaddictionantagonistawakebasecocaine self-administrationcravingdisorder later incidence preventiondopamine transporterdopaminergic neurondrug abstinencedrug cravingdrug reinforcementgenetic manipulationhypocretinin vivoinsightinterdisciplinary approachmesolimbic systemmotivated behaviorneurochemistryneuromechanismneurotransmissionnovelorexin A receptorpreventpsychostimulantpublic health relevancereceptorrelapse riskrelating to nervous systemresponsestimulant dependence
项目摘要
Project Summary:
Psychostimulant addiction is a chronic disease and currently no approved pharmacotherapies exist for its
treatment. Among the greatest challenges in the treatment of addiction is the prevention of relapse to drug use.
In animals, periods of abstinence following drug use intensifies craving and motivation for drug, which has
been associated with increased propensity for relapse. Recent advances suggest that alterations in mesolimbic
dopamine systems during abstinent periods may be a critical component of the intensification of drug craving
effect. Unfortunately, dopamine-based therapies are often ineffective or intolerable and may have abuse
potential themselves. The hypocretins/orexins (HCRT) are hypothalamic neuropeptides that participate in the
regulation of arousal, locomotor activity, and a variety of motivated behaviors. Over the past decade, the HCRT
system has also been shown to influence drug reinforcement via actions in the dopamine-rich ventral
tegmental area. For example, we have shown that disrupting HCRT neurotransmission within the ventral
tegmental area reduces the reinforcing effects of cocaine and attenuates cocaine-induced elevations in
dopamine within the nucleus accumbens. Recently we discovered a novel effect of acute HCRT disruption that
causes long-lasting alterations in dopamine terminal sensitivity to cocaine and prevents increased motivation
for cocaine following drug abstinence. To further examine the extent to which the HCRT system regulates
dopamine signaling and cocaine reinforcement, the proposed research will employ a multidisciplinary approach
using sophisticated behavioral, neurochemical, and genetic manipulation techniques. Studies will examine the
utility of acute HCRT receptor 1 blockade on the development of intensified behavioral and dopaminergic
responses to cocaine following a period of abstinence and whether these effects are dependent on dopamine
neurons of the ventral tegmental area. Completion of this work will offer insight into the neural mechanisms
underlying the addiction process and will provide the basis for a novel pharmacotherapy to treat cocaine
addiction.
项目概要:
精神兴奋剂成瘾是一种慢性疾病,目前还没有批准的药物治疗其
治疗戒毒治疗方面的最大挑战之一是预防吸毒复吸。
在动物中,药物使用后的禁欲期会加剧对药物的渴望和动机,
与复发倾向的增加有关。最近的进展表明,中脑边缘系统的改变
戒断期的多巴胺系统可能是药物渴望加剧的关键组成部分
效果不幸的是,多巴胺为基础的治疗往往是无效的或无法忍受的,并可能有滥用
潜力本身。下丘脑分泌素/食欲素(HCRT)是下丘脑神经肽,参与下丘脑的神经活动。
调节唤醒、运动活动和各种动机行为。在过去的十年里,HCRT
系统也被证明通过多巴胺丰富的腹侧神经元的作用影响药物强化。
被盖区例如,我们已经证明,在腹侧破坏HCRT神经传递,
被盖区减少可卡因的强化作用,并减弱可卡因诱导的
多巴胺在脑桥核内。最近,我们发现了急性HCRT中断的新效应,
导致对可卡因的多巴胺末端敏感性的长期改变,并阻止动机的增加
在戒毒后服用可卡因为了进一步研究HCRT系统调节
多巴胺信号和可卡因强化,拟议的研究将采用多学科的方法,
运用复杂的行为神经化学和基因操控技术研究将检查
急性HCRT受体1阻滞剂对强化行为和多巴胺能神经元损伤的作用
在一段时间的禁欲后对可卡因的反应以及这些作用是否依赖于多巴胺
腹侧被盖区的神经元。这项工作的完成将提供深入了解神经机制
这是成瘾过程的基础,并将为治疗可卡因的新药物疗法提供基础。
成瘾
项目成果
期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pharmacologically increasing microtubule acetylation corrects stress-exacerbated effects of organophosphates on neurons.
在药理学上增加的微管乙酰化校正了有机磷酸盐对神经元的应激效果。
- DOI:10.1111/tra.12489
- 发表时间:2017-07
- 期刊:
- 影响因子:0
- 作者:Rao AN;Patil A;Brodnik ZD;Qiang L;España RA;Sullivan KA;Black MM;Baas PW
- 通讯作者:Baas PW
Restoring lost nigrostriatal fibers in Parkinson's disease based on clinically-inspired design criteria.
- DOI:10.1016/j.brainresbull.2021.07.016
- 发表时间:2021-10
- 期刊:
- 影响因子:3.8
- 作者:Gordián-Vélez WJ;Chouhan D;España RA;Chen HI;Burdick JA;Duda JE;Cullen DK
- 通讯作者:Cullen DK
Hypocretin / Orexin Receptor 1 Knockdown in GABA or Dopamine Neurons in the Ventral Tegmental Area Differentially Impact Mesolimbic Dopamine and Motivation for Cocaine.
腹侧被盖区 GABA 或多巴胺神经元中的下丘脑分泌素 / 食欲素受体 1 敲低对中脑边缘多巴胺和可卡因动机产生不同影响。
- DOI:10.1016/j.addicn.2023.100104
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Black,EmilyM;Samels,ShannaB;Xu,Wei;Barson,JessicaR;Bass,CarolineE;Kortagere,Sandhya;España,RodrigoA
- 通讯作者:España,RodrigoA
Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention.
选择性激活多巴胺 D3 受体和去甲肾上腺素转运蛋白阻断可增强持续注意力。
- DOI:10.1016/j.neuropharm.2019.01.003
- 发表时间:2019
- 期刊:
- 影响因子:4.7
- 作者:Marshall,CourtneyA;Brodnik,ZacharyD;Mortensen,OleV;Reith,MaartenEA;Shumsky,JedS;Waterhouse,BarryD;España,RodrigoA;Kortagere,Sandhya
- 通讯作者:Kortagere,Sandhya
Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease.
- DOI:10.1002/term.2698
- 发表时间:2018-07
- 期刊:
- 影响因子:3.3
- 作者:Struzyna LA;Browne KD;Brodnik ZD;Burrell JC;Harris JP;Chen HI;Wolf JA;Panzer KV;Lim J;Duda JE;España RA;Cullen DK
- 通讯作者:Cullen DK
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rodrigo A. España其他文献
Rodrigo A. España的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rodrigo A. España', 18)}}的其他基金
Sleep Disturbances During Cocaine Abstinence, Dopamine Adaptations, and Motivation for Cocaine
可卡因戒断期间的睡眠障碍、多巴胺适应和可卡因动机
- 批准号:
10681668 - 财政年份:2023
- 资助金额:
$ 37.12万 - 项目类别:
Selective real-time activation of ERK1/2 signaling in dopamine neurons
多巴胺神经元中 ERK1/2 信号的选择性实时激活
- 批准号:
10706605 - 财政年份:2022
- 资助金额:
$ 37.12万 - 项目类别:
Selective real-time activation of ERK1/2 signaling in dopamine neurons
多巴胺神经元中 ERK1/2 信号的选择性实时激活
- 批准号:
10539173 - 财政年份:2022
- 资助金额:
$ 37.12万 - 项目类别:
Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Reinforcement
下丘脑分泌素/食欲素对多巴胺信号传导和可卡因强化的调节
- 批准号:
8996680 - 财政年份:2013
- 资助金额:
$ 37.12万 - 项目类别:
Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Reinforcement
下丘脑分泌素/食欲素对多巴胺信号传导和可卡因强化的调节
- 批准号:
9196339 - 财政年份:2013
- 资助金额:
$ 37.12万 - 项目类别:
Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Reinforcement
下丘脑分泌素/食欲素对多巴胺信号传导和可卡因强化的调节
- 批准号:
8788514 - 财政年份:2013
- 资助金额:
$ 37.12万 - 项目类别:
Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Reinforcement
下丘脑分泌素/食欲素对多巴胺信号传导和可卡因强化的调节
- 批准号:
8438911 - 财政年份:2013
- 资助金额:
$ 37.12万 - 项目类别:
Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Reinforcement
下丘脑分泌素/食欲素对多巴胺信号传导和可卡因强化的调节
- 批准号:
8600248 - 财政年份:2013
- 资助金额:
$ 37.12万 - 项目类别:
Hypocretin/Orexin Modulation of Reward and Addiction Processes
下丘脑分泌素/食欲素对奖赏和成瘾过程的调节
- 批准号:
7860686 - 财政年份:2008
- 资助金额:
$ 37.12万 - 项目类别:
Hypocretin/Orexin Modulation of Reward and Addiction Processes
下丘脑分泌素/食欲素对奖赏和成瘾过程的调节
- 批准号:
8084181 - 财政年份:2008
- 资助金额:
$ 37.12万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 37.12万 - 项目类别:
Operating Grants